KY
Kevin Yee
Assistant Professor of Medicine, School of Medicine · Oregon Health & Science University
Credentials: · · · ·
History
- 1996–1999
University of California
1992–1996
Research
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
Blood · 2003 · 722 citations
SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase
Blood · 2002 · First of 9 authors · 159 citations
Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells
Blood · 2004 · First of 8 authors · 106 citations
- MH
7 papers
- GH
2 papers
2 papers
- AA
1 paper
1 paper
- BS
1 paper
1 paper
- CW
1 paper
